Search

everythinglearnresearchcommunity

for

Search:↓

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

GI197111X is best dissolved in Capmul MCM for trials.

An elderly Chinese man lost all his hair after taking a new heart medication.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

MK-5108 is safe and shows potential against tumors, especially alone.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Tideglusib helps heal wounds in older skin.

Baricitinib is effective as a treatment for severe hair loss.

Baricitinib successfully treated severe hair loss.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Aumolertinib effectively controls lung cancer and improves quality of life.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

New inhibitors may reduce gut toxicity from cancer drugs.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.